Zivo Bioscience, Inc.
ZIVO
$14.85
-$0.15-1.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 174.90K | 121.50K | 157.20K | 79.00K | 59.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 174.90K | 121.50K | 157.20K | 79.00K | 59.30K |
| Cost of Revenue | 120.60K | 85.10K | 108.30K | 53.00K | 38.60K |
| Gross Profit | 54.40K | 36.50K | 49.00K | 26.10K | 20.70K |
| SG&A Expenses | 5.93M | 10.74M | 10.28M | 10.48M | 9.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.87M | 16.42M | 13.52M | 13.74M | 13.03M |
| Operating Income | -9.70M | -16.29M | -13.36M | -13.66M | -12.97M |
| Income Before Tax | -9.72M | -16.32M | -13.38M | -13.69M | -13.25M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.72 | -16.32 | -13.38 | -13.69 | -13.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.72M | -16.32M | -13.38M | -13.69M | -13.25M |
| EBIT | -9.70M | -16.29M | -13.36M | -13.66M | -12.97M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -2.67 | -5.02 | -4.36 | -4.90 | -5.29 |
| Normalized Basic EPS | -1.67 | -3.14 | -2.73 | -3.06 | -3.30 |
| EPS Diluted | -2.67 | -5.02 | -4.36 | -4.90 | -5.29 |
| Normalized Diluted EPS | -1.67 | -3.14 | -2.73 | -3.06 | -3.30 |
| Average Basic Shares Outstanding | 14.51M | 13.67M | 12.66M | 11.05M | 9.37M |
| Average Diluted Shares Outstanding | 14.51M | 13.67M | 12.66M | 11.05M | 9.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |